• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SenesTech Reports Record Direct-to-Consumer and Subscription Growth Following Strategic E-Commerce Transition

    5/12/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials
    Get the next $SNES alert in real time by email

    In-house e-commerce transition and new CEO expected to support scalable recurring revenue growth strategy

    SURPRISE, Ariz., May 12, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products today announced financial results for the first quarter ended March 31, 2026 and provided an update on the Company's acceleration of revenue under newly appointed Chief Executive Officer, Michael Edell.

    SenesTech, Inc. is a pioneer in fertility control solutions for managing rodent populations. (PRNewsfoto/SenesTech, Inc.)

    Q1 2026 Financial Highlights

    • Revenue increased 2% to $493,000 in Q1 2026 compared to $485,000 in Q1 2025, despite approximately $157,000 of reduced third-party e-commerce revenue associated with the Company's transition from third-party e-commerce management to in-house management of Amazon sales. Gross profit increased 8% to $338,000 in Q1 2026 compared to $313,000 in Q1 2025.
    • Direct-to-consumer revenue increased 42% to $194,000 in Q1 2026, compared to $137,000 in Q1 2025, driven by strong Amazon execution and continued subscription growth.
    • Subscription revenue increased 44% to $56,000 in Q1 2026, compared to $39,000 in Q1 2025, reinforcing the recurring nature of the Company's growing direct-to-consumer business model.
    • Third party e-commerce revenues declined to $17,000 in Q1 2026 compared to $157,000 in Q1 2025 due to the transition to managing Amazon efforts internally.
    • B2B revenue increased 57% to $298,000 in Q1 2026 compared to $190,000 in Q1 2025, reflecting continued traction across distributor, municipal, and professional channels.
    • Gross margin expanded to a company record 68.6% in Q1 2026 as direct channel economics improved and pricing discipline strengthened.
    • Net loss for Q1 2026 was $2.1 million, compared to $1.7 million in Q1 2025. Q1 2026 included $443,000 in severance costs and one-time legal expenses.
    • Adjusted EBITDA loss was $1.6 million in Q1 2026, compared to $1.5 million in Q1 2025.
    • Cash and equivalents totaled $6.8 million at quarter end, supporting ongoing operational execution and strategic initiatives.

    April 2026 E-Commerce Momentum

    • April 2026 represented the first full month following completion of the Company's Amazon transition from third-party e-commerce management to direct in-house management.
    • E-commerce sales for April 2026 increased 163% to a record $146,000 compared to $56,000 during April 2025 and increased 47% compared to $99,000 during March 2026, providing early positive evidence for the Company's evolving e-commerce strategy.
    • Subscription-based revenue increased 198% to a record $36,000 during April 2026 compared to $12,000 during April 2025, while subscription-based customers increased 109%, reinforcing the recurring nature of the Company's growing direct-to-consumer business model.

    Recent Operational and Strategic Highlights

    • Appointment of New CEO: Michael Edell's appointment as President and Chief Executive Officer in May 2026 reinforces SenesTech's focus on operational accountability, scalable growth, and disciplined execution. During his tenure as Interim Chief Operating Officer, Mr. Edell helped accelerate the Company's direct-to-consumer strategy, including the transition to direct Amazon management, subscription growth initiatives, packaging redesign efforts, and broader go-to-market execution across e-commerce, distributor, municipal, and other B2B channels.
    • Amazon Direct Management Transition Completed: SenesTech substantially completed its transition from third party e-commerce management of Amazon sales of Evolve products during March 2026. The transition provides the Company with greater visibility into customer behavior, enhanced control over advertising and media buying, improved pricing visibility, stronger customer engagement opportunities, and greater control over overall channel economics.
    • E-Commerce Website Redesign Underway: SenesTech continues to redesign the e-commerce section of SenesTech.com to improve customer experience, simplify navigation, increase conversion rates, and support subscription growth. The redesign is expected to align closely with updated packaging, digital advertising initiatives, and broader consumer marketing efforts, with launch currently targeted for Q3 2026.
    • B2B Vertical Expansion Strategy: SenesTech continues to refine its B2B strategy with increased focus on large-scale opportunities across targeted verticals including pest management, agriculture, municipalities, distributors, and other commercial markets capable of generating larger dollar opportunities. The emphasis on direct-to-consumer growth is also expected to support B2B revenues through increased brand awareness and inbound lead generation.
    • Packaging Refresh Initiative: SenesTech is implementing updated packaging designed to improve online and shelf visibility and strengthen differentiation.
    • Municipal Deployment Growth: SenesTech continues to see increased municipal deployment activity across major urban markets, including Chicago, Boston, Washington, D.C., and New York City. The previously announced 12-month New York City rat contraception pilot program is expected to conclude this month.
    • International Activity: SenesTech continues to pursue international expansion opportunities on an opportunistic basis, with a focus on countries that can move efficiently through the regulatory process with minimal incremental cost to the Company.

    Management Commentary

    "SenesTech is entering a new phase where we are building a more scalable, data-driven and recurring revenue business model around the growing demand for non-poison rodent management solutions," said Michael Edell, Chief Executive Officer of SenesTech. "The strategic transition to directly managing our Amazon business and revamping our online e-commerce store has significantly improved our visibility into customer behavior, advertising performance, subscriptions, and overall channel economics. We are already seeing strong momentum in our direct-to-consumer business, particularly through accelerating subscription adoption and improved Amazon execution."

    Mr. Edell continued, "Our efforts across Amazon, Shopify, packaging redesign, digital media buying, subscriptions, and customer engagement are all connected initiatives intended to reduce friction, improve conversion, increase customer retention, and create a stronger recurring revenue foundation. At the same time, we remain focused on improving operational discipline, maintaining strong gross margins and positioning the Company for scalable long-term growth."

    "Our first quarter results reflected the expected temporary disruption associated with transitioning Amazon operations in-house, however the underlying consumer demand trends and April proof points were highly encouraging," said Tom Chesterman, Chief Financial Officer of SenesTech. "Direct-to-consumer revenue increased 42% to a record $194,000 during Q1, gross margin expanded to a Company record 68.6%, and subscription-based sales continued to accelerate breaking past revenue numbers. We believe these trends support the long-term strategic value of directly controlling our e-commerce channels and building a more predictable recurring revenue mix."

    Use of Non-GAAP Measure

    Adjusted EBITDA and Adjusted Net Loss are non-GAAP measures. However, these measures are not intended to be a substitute for those financial measures reported in accordance with GAAP. These measures have been included because management believes that, when considered together with the GAAP figures, they provide meaningful information related to operating performance and liquidity trends. We use these non-GAAP financial measures as part of our overall assessment of our performance, including the preparation of our annual operating budget and quarterly forecasts, to evaluate the effectiveness of our business strategies, and to communicate with our board of directors concerning our financial performance. These adjustments may be calculated by us differently than other companies that disclose measures with the same or similar term. See our attached financials for a reconciliation of the non-GAAP measures to the nearest GAAP measure.

    Conference Call Details

    Date: Tuesday, May 12, 2026.

    Time: 5:00 p.m. ET.

    Webcast: https://app.webinar.net/m976bqQblKE. 

    Webcast Replay: Available for 90 days on the Company's website.

    About SenesTech

    SenesTech is committed to creating healthier environments by managing animal pest populations through birth control. The Company's groundbreaking products, including Evolve rodent birth control, integrate seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech's mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are effective and sustainable.

    For more information visit https://senestech.com/. 

    Safe Harbor Statement

    This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, among others, statements regarding the acceleration of the Company's direct-to-consumer and e-commerce initiatives, the recurring nature of the Company's growing director-to-consumer business model, any growth attributable to the appointment of the Company's new CEO, the Company's efforts in driving B2B revenues, any increases in conversion rates and subscription growth, and any international expansion opportunities for the Company.

    Forward-looking statements may describe future expectations, plans, results, or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the successful commercialization of our products; market acceptance of our products; our financial performance, including our ability to fund operations; regulatory approval and regulation of our products; challenges transitioning to direct management of Amazon sales of Evolve products or the results of such direct management not being as expected; having to use cash at times and in ways other than as planned; and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2025. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

    CONTACT:

    Investors: Robert Blum, Lytham Partners, LLC, (602) 889-9700, senestech@lythampartners.com 

    Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., (928) 779-4143

     

    SENESTECH, INC.

    BALANCE SHEETS

    (In thousands, except share and per share data)

    (Unaudited)





    March 31,

    2026



    December 31,

    2025

    ASSETS







    Current assets:







    Cash and cash equivalents

    $          6,804



    $            7,575

    Short-term investments

    —



    994

    Accounts receivable, net

    163



    201

    Inventory

    1,048



    994

    Prepaid expenses and other current assets

    338



    297

    Total current assets

    8,353



    10,061

    Right to use asset, operating lease

    2,295



    2,336

    Property and equipment, net

    379



    410

    Other noncurrent assets

    36



    36

    Total assets

    $        11,063



    $          12,843









    LIABILITIES AND STOCKHOLDERS' EQUITY







    Current liabilities:







    Accounts payable

    $             115



    $               183

    Accrued expenses

    593



    383

    Current portion of operating lease liability

    142



    139

    Current portion of notes payable

    63



    61

    Deferred revenue

    25



    32

    Total current liabilities

    938



    798

    Operating lease liability, less current portion

    2,296



    2,332

    Notes payable, less current portion

    128



    145

    Total liabilities

    3,362



    3,275

    Stockholders' equity:







    Common stock

    5



    5

    Additional paid-in capital

    152,239



    152,043

    Accumulated deficit

    (144,543)



    (142,480)

    Total stockholders' equity

    7,701



    9,568

    Total liabilities and stockholders' equity

    $        11,063



    $          12,843

     

    SENESTECH, INC.

    STATEMENTS OF OPERATIONS

    (In thousands, except share and per share data)

    (Unaudited)





    Three Months Ended

    March 31,



    2026



    2025

    Revenues, net

    $          493



    $          485

    Cost of sales

    155



    172

    Gross profit

    338



    313

    Operating expenses:







    Research and development

    422



    418

    Selling, general and administrative

    2,035



    1,558

    Total operating expenses

    2,457



    1,976

    Loss from operations

    (2,119)



    (1,663)

    Interest income (expense), net

    56



    (2)

    Net loss

    $      (2,063)



    $      (1,665)

    Weighted average shares outstanding — basic and diluted

    5,263,717



    1,299,971

    Loss per share — basic and diluted

    $        (0.39)



    $        (1.28)

     

    SENESTECH, INC.

    Itemized Reconciliation Between Net Loss and Adjusted EBITDA (non-GAAP)

    (In thousands)

    (Unaudited)





    Three Months Ended

    March 31,



    2026



    2025

    Net loss (as reported, GAAP)

    $      (2,063)



    $      (1,665)

    Non-GAAP adjustments:







    Severance costs

    230



    27

    One-time legal costs

    213



    45

    Interest income, net

    (56)



    2

    Stock-based compensation expense

    23



    91

    Depreciation expense

    31



    39

    Non-cash operating lease expense

    8



    —

    Total non-GAAP adjustments

    449



    204

    Adjusted EBITDA loss (non-GAAP)

    $      (1,614)



    $      (1,461)

     

    SenesTech Inc.

    Reconciliation of Net Loss and Adjusted Net Loss (non-GAAP)

    (In thousands)

    (Unaudited)





    Three Months Ended

    March 31,



    Percent

    Change



    2026



    2025



    Net loss (as reported, GAAP)

    $        (2,063)



    $        (1,665)



    24 %

    Non-GAAP adjustments:











    Severance costs

    230



    27





    One-time legal costs

    213



    45





    Adjusted net loss (non-GAAP)

    $        (1,620)



    $        (1,593)



    2 %

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/senestech-reports-record-direct-to-consumer-and-subscription-growth-following-strategic-e-commerce-transition-302769942.html

    SOURCE SenesTech, Inc.

    Get the next $SNES alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SNES

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SNES
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $53,486 worth of shares (32,120 units at $1.67) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    5/18/26 8:11:14 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Chief Executive Officer Edell Michael bought $5,013 worth of shares (3,000 units at $1.67) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    5/18/26 4:40:22 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $4,407 worth of shares (3,000 units at $1.47) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    4/30/26 7:19:04 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SenesTech Expands Distribution of Evolve® Rodent Birth Control™ into Bermuda

    SURPRISE, Ariz., June 4, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in birth control solutions for managing rodent populations, today announced the expansion of its Evolve® Rodent Birth Control™ products into Bermuda through a distribution agreement with Animal and Garden House, marking another step in the Company's growing presence in environmentally sensitive island markets. "Bermuda presents a unique environment for pest management solutions. As a small island with a dense population and close proximity between urban areas and surrounding marine ecosystems, the use of traditional rodenticides has long requi

    6/4/26 8:00:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Announces Amendment to Equity Incentive Plan Proposal

    PHOENIX, June 3, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) ("SenesTech" or the "Company"), today announced that its Board of Directors has approved an amendment to the proposed changes to the Company's 2018 Equity Incentive Plan (the "2018 Plan"), which is being presented for stockholder approval at the Company's 2026 Annual Meeting of Stockholders scheduled for June 9, 2026. As previously disclosed in the Company's definitive Proxy Statement filed on April 29, 2026, stockholders are being asked to approve an amendment to the 2018 Plan to increase the number of shares available for future equity awards. Following furth

    6/3/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026

    SURPRISE, Ariz., May 19, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2026 Investor Conference, taking place virtually on Thursday, May 28, 2026. Company WebcastThe webcast presentation will take place at 2:30 p.m. ET on Thursday, May 28, 2026. The webcast can be accessed by visiting the conference home page at http

    5/19/26 4:30:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    SEC Filings

    View All

    SEC Form DEFA14A filed by SenesTech Inc.

    DEFA14A - SenesTech, Inc. (0001680378) (Filer)

    6/4/26 4:02:35 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SEC Form DEFA14A filed by SenesTech Inc.

    DEFA14A - SenesTech, Inc. (0001680378) (Filer)

    6/3/26 4:06:13 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SEC Form DEFA14A filed by SenesTech Inc.

    DEFA14A - SenesTech, Inc. (0001680378) (Filer)

    5/27/26 4:01:48 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $53,486 worth of shares (32,120 units at $1.67) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    5/18/26 8:11:14 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Chief Executive Officer Edell Michael bought $5,013 worth of shares (3,000 units at $1.67) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    5/18/26 4:40:22 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $4,407 worth of shares (3,000 units at $1.47) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    4/30/26 7:19:04 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Leadership Updates

    Live Leadership Updates

    View All

    SenesTech Appoints Michael Edell as President and Chief Executive Officer to Drive Revenue Growth and Scalable Sales Channels

    SURPRISE, Ariz., May 7, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", )), a leader in humane pest control solutions, today announced the appointment of Michael Edell as President and Chief Executive Officer, effective May 6, 2026. The Company also announced Board leadership transition updates to support SenesTech's next phase of commercial growth and operational execution. Mr. Edell brings a proven track record of building and scaling consumer product businesses, with deep expertise in e-commerce, direct-to-consumer execution, and business

    5/7/26 8:30:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Announces CEO Transition Plan

    Board To Initiate Search For New Leadership As Current CEO Plans Retirement Dr. Jamie Bechtel Named Interim Executive Chair To Further Support Transition PHOENIX, Jan. 28, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a pioneer in fertility control solutions for managing rodent populations, today announced that Joel Fruendt, President and Chief Executive Officer, has informed the Board of Directors of his intent to retire. The Board will commence a formal search for a successor. Mr. Fruendt will continue to serve as President and CEO until the search is completed or until June 30, 2026, whichever occurs first.

    1/28/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Names Nicole Williams as Chief Revenue Officer

    PHOENIX, Feb. 16, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today reported the appointment of Nicole Williams as Chief Revenue Officer. Ms. Williams was previously Chief Strategy Officer, and this appointment is part of an expansion and restructuring of the sales organization and commercialization efforts. The restructuring of the team comes after yet another quarter and fiscal ye

    2/16/23 9:00:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Financials

    Live finance-specific insights

    View All

    SenesTech Reports Record Direct-to-Consumer and Subscription Growth Following Strategic E-Commerce Transition

    In-house e-commerce transition and new CEO expected to support scalable recurring revenue growth strategySURPRISE, Ariz., May 12, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products today announced financial results for the first quarter ended March 31, 2026 and provided an update on the Company's acceleration of revenue under newly appointed Chief Executive Officer, Michael Edell. Q1 2026 Financial HighlightsRevenue increased 2% to $493,

    5/12/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026

    Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern timePHOENIX, May 7, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products, will report financial results for its first quarter 2026, ended March 31, 2026, after the market close on Tuesday, May 12, 2026. The Company has scheduled a conference call that same day, Tuesday, May 12, 2026, at 5:00 pm ET, to review the results. First Quarter

    5/7/26 4:30:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Announces 2025 Financial Results Driven by Strong Growth in E-Commerce

    SURPRISE, Ariz., March 12, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in birth control solutions for managing rodent populations, today announced financial results for the fourth quarter and the full year ended December 31, 2025. 2025 HighlightsRevenue increased by 20% to $2.2 million in 2025 as compared to 2024, driven by strong growth in the Company's overall e-commerce channels despite the impact associated with the Company's transition to directly managing Amazon sales of Evolve® Rat and Evolve Mouse. Excluding this transition-related impact, we estimate re

    3/12/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by SenesTech Inc.

    SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

    11/14/24 7:28:08 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by SenesTech Inc.

    SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

    11/14/24 7:12:23 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SEC Form SC 13G filed by SenesTech Inc.

    SC 13G - SenesTech, Inc. (0001680378) (Subject)

    11/12/24 4:30:48 PM ET
    $SNES
    Agricultural Chemicals
    Industrials